Recombinant Human DDR1/CD167a Protein，His

DDR1, also known as CD167a, is a receptor tyrosine kinase that plays a crucial role in various cell processes such as migration, differentiation, and tissue remodeling, particularly in the context of the extracellular matrix. It is primarily expressed in cells of mesenchymal origin and is implicated in several pathological conditions, including cancer, fibrosis, and inflammatory diseases. The study of DDR1 has gained attention due to its involvement in the tumor microenvironment, where it is believed to influence tumor progression and metastasis. Research on recombinant DDR1/CD167a proteins has been pivotal in understanding its structural and functional properties, providing insights into its ligand-binding mechanisms and signaling pathways. By creating these recombinant proteins, scientists can explore the receptor's interactions with ligands like collagen, analyze its role in cellular signaling, and evaluate its potential as a therapeutic target. Furthermore, understanding the biophysical properties of DDR1 reaffirms its significance in cell behavior and offers opportunities for the development of novel treatment strategies aimed at modulating its activity in disease contexts. Consequently, the exploration of DDR1/CD167a recombinant proteins is not only essential for elucidating its biological functions but also for the advancement of targeted therapies aimed at various diseases linked to this receptor.